Diagnostic accuracies for parent artery patency of NC-MRA for each separate device, for patients treated with FD exclusively and those treated with additional device
| Pipeline Shield (n = 28) | Surpass Evolve (n = 19) | Silk Vista Baby (n = 9) | FD Exclusively (n = 22) | Additional Device (n = 34) | |
|---|---|---|---|---|---|
| Specificity (95% CI) | 0.96 (0.78–1.00) | 0.57 (0.29–0.82) | 1 (0.48–1.00) | 0.87 (0.60–0.98) | 0.81 (0.62–0.94) |
| PPV (95% CI) | 0.80 (0.28–0.99) | 0.45 (0.17–0.77) | 1 (0.40–1.00) | 0.78 (0.40–0.97) | 0.55 (0.23–0.83) |
| Sensitivity (95% CI) | 0.80 (0.28–0.99) | 1 (0.48–1.00) | 1 (0.40–1.00) | 1 (0.59–1.00) | 0.86 (0.42–1.00) |
| NPV (95% CI) | 0.96 (0.78–1.00) | 1 (0.63–1.00) | 1 (0.48–1.00) | 1 (0.75–1.00) | 0.96 (0.78–1.00) |